Kaletra (Lopinavir/Ritonavir): Research
- Lopinavir/Ritonavir Equivalent to Nevirapine in Ugandan Children (March 14, 2013)
From aidsmap.com
- HIV Drug Not Tied to Premature Births (March 8, 2013)
From MedPage Today
- Lopinavir/Ritonavir in Pregnancy: Results From a Systematic Review (January/February 2013)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Simplified Protease Inhibitor Monotherapy Fails to Maintain HIV Suppression (October 26, 2012)
From HIVandHepatitis.com
- Simplifying HAART Regimen Fails to Maintain HIV-1 Viral Suppression (October 23, 2012)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
On TheBodyPRO.com
- Novel Lopinavir/Ritonavir Sprinkle Formulation for Children in Resource-Limited Settings (July/August 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Lopinavir/Ritonavir Monotherapy in Children (March/April 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Lower Malaria Risk in Children Receiving Lopinavir/Ritonavir-Based Compared to NNRTI-Based ART (March/April 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- ARV Given to HIV-Positive Children Boosts Preventive Power of Key Malaria Drug, Study Shows (March 15, 2012)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
On TheBodyPRO.com
- The Effect of BMI on Efficacy, Safety and Tolerability of Lopinavir/r in Women (January/February 2012)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
- Lopinavir and Rifampicin Interaction in HIV-Positive Patients (July/August 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Raltegravir Combined With Kaletra Associated With Good Preservation of Bone Density Over 96 Weeks (July 19, 2011)
From aidsmap.com
- Kaletra Can Cause Kidney Problems in Newborns (July 5, 2011)
In Los Angeles Times
- HIV Drug Could Lead to New Cervical Cancer Treatment (May 3, 2011)
- Lopinavir Troughs Lower in Children on Once-Daily Dose With Efavirenz (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Lopinavir/r Reduces Levels of Rifabutin (May/June 2011)
To read PDF, click here.
In HIV Treatment Bulletin, from HIV i-Base
On TheBodyPRO.com
- Kaletra Superior to Viramune in HIV-Positive Infants, U.S. Study Finds (November 3, 2010)
From National Institute of Allergy and Infectious Diseases
On TheBodyPRO.com
- Raltegravir/Kaletra Combination Does Well (July 21, 2010)
A "nuke-sparing" combination of the integrase inhibitor raltegravir (Isentress) and the protease inhibitor drug lopinavir/ritonavir (Kaletra) looks highly promising, according to research presented to the conference.
From aidsmap.com
- Kaletra/Isentress Shows Promise as HIV Nuceleoside-Sparing Regimen for First-Line Treatment (July 20, 2010)
From AIDSmeds.com
- New Drugs and Simplified Treatments Demonstrate Potential for Treating HIV (AIDS 2010) (About Kaletra, Isentress, TBR-65 and S/GSK1349572) (July 20, 2010)
In The AIDS Beacon
- First-Line Lopinavir/r/Raltegravir (With No NRTIs) in Treatment Naive (July 19, 2010)
From National AIDS Treatment Advocacy Project
|
Advertisement
|
Email
Glossary
